Bender Robert & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.3M | Sell |
|
|||||
|
2025
Q2 | $11.9M | Sell |
|
|||||
|
2025
Q1 | $13.1M | Sell |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $12.6M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $11.8M | Sell |
|
|||||
|
2023
Q4 | $11.6M | Buy |
|
|||||
|
2023
Q3 | $9.89M | Buy |
|
|||||
|
2023
Q2 | $10M | Sell |
|
|||||
|
2023
Q1 | $9.09M | Sell |
|
|||||
|
2022
Q4 | $8.33M | Buy |
|
|||||
|
2022
Q3 | $8.35M | Buy |
|
|||||
|
2022
Q2 | $7.94M | Sell |
|
|||||
|
2022
Q1 | $7.42M | Sell |
|
|||||
|
2021
Q4 | $5.46M | Hold |
|
|||||
|
2021
Q3 | $5.46M | Sell |
|
|||||
|
2021
Q2 | $6.13M | Buy |
|
|||||
|
2021
Q1 | $6.48M | Buy |
|